November 13, 2007 -- Synthes (VRX: SYNT), a major Swiss medical device maker, acquired N Spine, a cross-border company that develops and markets spinal dynamic stabilization devices. The all-cash deal includes $35 million upfront, another $45 million in milestones, plus a significant earnout. The acquisition shows that cross-border angel investments can be used successfully to bring a biomedical product to market, ultimately finding a satisfactory exit for investors and founders. Life Science Angels, Inc., was the lead investor in NSpine. More details...
